IRIS
DAVID, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.234
AS - Asia 2.925
EU - Europa 1.781
SA - Sud America 338
AF - Africa 105
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.389
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.155
SG - Singapore 1.173
CN - Cina 825
IE - Irlanda 362
VN - Vietnam 359
IT - Italia 272
BR - Brasile 261
SE - Svezia 251
FI - Finlandia 242
HK - Hong Kong 219
DE - Germania 198
UA - Ucraina 170
TR - Turchia 116
BD - Bangladesh 101
NL - Olanda 88
FR - Francia 75
ZA - Sudafrica 75
CA - Canada 60
RU - Federazione Russa 41
GB - Regno Unito 39
AR - Argentina 24
IN - India 24
IQ - Iraq 17
EC - Ecuador 16
UZ - Uzbekistan 15
BE - Belgio 12
VE - Venezuela 10
ES - Italia 9
PH - Filippine 9
CL - Cile 8
PK - Pakistan 8
MX - Messico 7
PL - Polonia 7
TH - Thailandia 7
TN - Tunisia 7
ID - Indonesia 6
LB - Libano 6
JO - Giordania 5
JP - Giappone 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
AT - Austria 4
CO - Colombia 4
KR - Corea 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
CI - Costa d'Avorio 3
DZ - Algeria 3
EG - Egitto 3
JM - Giamaica 3
KE - Kenya 3
OM - Oman 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
BH - Bahrain 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
UY - Uruguay 2
BB - Barbados 1
BG - Bulgaria 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LK - Sri Lanka 1
MK - Macedonia 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 8.389
Salva come PNG Salva come JPEG
Città #
Singapore 568
Ashburn 374
Dublin 360
Chandler 347
San Jose 331
Santa Clara 323
Jacksonville 303
Hong Kong 210
Beijing 201
Ho Chi Minh City 111
Izmir 106
Boardman 92
San Mateo 92
Nanjing 87
Dearborn 82
Hanoi 79
Princeton 77
Johannesburg 71
Ann Arbor 64
Lauterbourg 64
Los Angeles 59
Wilmington 50
Toronto 46
New York 44
Hebei 42
Dallas 41
Parma 41
Shenyang 40
Jinan 35
Helsinki 32
Moscow 32
Shanghai 32
Buffalo 26
Tianjin 24
Columbus 23
Kunming 23
Nanchang 23
Haiphong 22
São Paulo 21
Bologna 20
Changsha 19
Bremen 16
Council Bluffs 16
Jiaxing 15
Munich 15
Tashkent 15
Woodbridge 15
Des Moines 13
Hefei 13
Seattle 13
Zhengzhou 13
Genoa 12
Brussels 11
Da Nang 11
Guangzhou 11
Haikou 10
Rome 10
Norwalk 9
Nuremberg 9
Atlanta 8
Brooklyn 8
Frankfurt am Main 8
San Francisco 8
Chengdu 7
Hangzhou 7
Hải Dương 7
Montreal 7
Stockholm 7
The Dalles 7
Turku 7
Warsaw 7
Baghdad 6
Brasília 6
Fuzhou 6
Goiânia 6
Houston 6
Ningbo 6
Taiyuan 6
Can Tho 5
Caxias do Sul 5
Chicago 5
Duncan 5
Guayaquil 5
Kyiv 5
Lima 5
London 5
Napoli 5
Ninh Bình 5
Rio de Janeiro 5
Rockville 5
Amman 4
Auburn Hills 4
Bangkok 4
Belo Horizonte 4
Biên Hòa 4
Borås 4
Buenos Aires 4
Denver 4
Dhaka 4
Düsseldorf 4
Totale 5.094
Salva come PNG Salva come JPEG
Nome #
IL PROGETTO PIRP (PREVENZIONE INSUFFICIENZA RENALE PROGRESSIVA) DELLA REGIONE EMILIA-ROMAGNA: ANALISI DEI RISULTATI PRELIMINARI 225
CALCIFICASSI ESITATA IN GUARIGIONE DOPO TERAPIA CON TIOSOLFATO 165
Burnout in health care providers of dialysis service in Northern Italy—a multicentre study 151
HEMOFILTRATION AND HEMODIAFILTRATION REDUCEINTRADIALYTIC HYPOTENSION IN ESRD 147
CLINICAL POLICIES ON THE MANAGEMENT OF CHRONIC KIDNEY DISEASE PATIENTS IN ITALY 146
IMPROVEMENT OF INTRADIALYTIC TOLERANCE WITH LOW VOLUME DIALYSIS AND BICARBONATE BUFFERING OF DIALYSATE. 145
2-h DIALYSIS: A REALISTIC GOAL ? 136
ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION INDUCES PROINFLAMMATORY ACTIVITY IN HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS. 135
A SIMPLE APPROACH FOR ASSESSING EQUILIBRATED KT/VB2M ON A ROUTINE BASIS. 134
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 134
CLINICAL EFFECTS OF ONLINE DIALYSATE AND INFUSION FLUIDS 132
ADHERENCE OF HUMAN MONOCYTES TO HAEMODIALYSIS MEMBRANES 132
ALTERNATIVE PATHWAY ACTIVATION OF COMPLEMENT BY CULTURED HUMAN PROXIMAL TUBULAR EPITHELIAL CELLS 132
Bacterial contamination of the dialysis fluid in different dialyzing machines 132
High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results 131
Albumin loss in on-line haemodiafiltration 131
EFFECTS OF ADD-ON FLUVASTATIN THERAPY IN PATIENTS WITH CHRONIC PROTEINURIC NEPHROPATHY ON DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE: THE ESPLANADE TRIAL 131
THE SIGNIFICANCE OF THE HBeAG/ANTI HBe SYSTEM IN HEMODIALYSISPATIENTS. A MULTICENTER STUDY. 128
Aliskiren Combined with Losartan in Type 2 Diabetesand Nephropathy 127
BEHAVIOUR OF B2-MICROGLOBULIN REMOVAL WITH DIFFERENT DIALYSIS SCHEDULES 124
BASIC THERAPEUTIC REQUIREMENTS IN THE TREATMENT OF SEPSIS IN ACUTE RENAL FAILURE 123
ADEQUACY OF TREATMENT OF UREMIA IN THE NINETIES 123
STORIA E PRINCIPI BIOFISICI GENERALI DELLE TECNICHE CONVETTIVE 122
GLUCOSE METABOLISM AND LARGER MOLECULE REMOVAL IN LONG-TERM HIGH-EFFICIENCY HEMOFILTRATION 122
HEMOFILTRATION: PREDILUTION VERSUS POSTDILUTION 122
Variable radiological lung nodule evaluation leads to divergent management recommendations 121
Severe acute valproic acid intoxication successfully treated with hemodiafiltration without hemoperfusion 120
An overview of hemodialysis and oxidant stress 119
A clinical stratification tool for chronic kidney disease progression rate based on classification tree analysis 119
Sarcoid granulomatous nephritis with isolated and reversible renal failure. A case report. 114
Identification of operational clues to dry weight prescription in hemodialysis using bioimpedance vector analysis 113
ASSOCIAZIONE TRA LIVELLI DI ACIDO URICO E RISCHIO DI PROGRESSIONE DELL’INSUFFICIENZA RENALE O DI MORTE PER OGNI CAUSA 113
CYCLOSPORIN A AND DRUG INTERACTION. 112
L'emodialisi e la dialisi peritoneale 110
PRESENTAZIONE DI UNA FORMULA PER IL CALCOLO IMMEDIATO DEL KT/V DELLA BETA2 MICROGLOBULINA 110
CORRECTION OF UREMIC ACIDOSIS BY HEMODIALYSIS 108
ROLE OF PLATELET ACTIVATING FACTOR IN HEMODIALYSIS. 107
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change 107
DANGER OF UNNECESSARILY PROLONGED DIALYSIS SESSION: CARPAL TUNNEL SYNDROME 104
Organic contamination in dialysis water: trichloroethylene as a model compound. 104
Tolerance to ultrafiltration in hemodialysis 103
PRE-POSTDILUTION HEMOFILTRATION 103
Alterations of the cytokine network in hemodialysis 103
REVERSIBLE ACUTE CYCLOSPORINE NEPHROTOXICITY INDUCED BY COLCHICINE ADMINISTRATION 103
Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. 100
Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC). 100
IL REBOUND E IL KT/V EQUILIBRATO DELLA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 99
Hemodiafiltration and high-flux hemodialysis with polyethersulfone membranes 97
Disinfection in dialysis, using aldehydes. Theoretical considerations and practical use 97
Long-term outcome and clinical significance of orthostatic proteinuria. 97
Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial 97
Urea in Exhaled Breath Condensate of Uraemics and Patients with Chronic Airway Diseases 96
THE EMILIA-ROMAGNA REGION PIRP PROGRAMME ( PREVENTION IN PROGRESSION OF PROGRESSIVE RENAL INSUFFICIENCY) 94
Preventing the epidemic of cardiovascular disease: new perspectives in extracorporeal substitutive treatment 92
THE HEMATOPOIETIC SYSTEM IN RENAL FAILURE 91
Urinary soluble CD14 mediates human proximal tubular epithelial cell injury induced by LPS 91
EFFETTI DELLA TERAPIA PROLUNGATA CON CALCITRIOLO SU FGF23 E SUL METABOLISMO CALCIO-FOSFORICO NELL’IRC. 91
Dialysis strategies 89
IRON-REPLETE HAEMODIALYSIS PATIENTS DO NOT REQUIRE HIGHER ERYTHROPOIETIN DOSAGES WHEN CONVERTING FROM SUBCUTANEOUS TO INTRAVENOUS ADMINISTRATION. RESULTS OF THE ITALIAN STUDY ON ERYTHROPOIETIN CONVERTING (ISEC). 89
TERAPIA CON CALCIFEDIOLO NEI PAZIENTI CON CKD E DEFICIT DI VITAMINA D. 88
Immunological aspects of urinary tract infections 86
TANDEM PLASMA-EXCHANGE (PE) DIALYSIS. UNA VARIANTE SEMPLIFICATA. 86
COMPARISON OF 3 AUTOMATED ASSAYS FOR C-REACTIVE PROTEIN IN END-STAGE RENAL DISEASE: CLINICAL AND EPIDEMIOLOGICAL IMPLICATIONS 84
PRODUCTION OF PLATELET ACTIVATING FACTOR BY HUMAN NEUTROPHILS AFTER BACKFILTRATION OF ENDOTOXIN CONTAMINATED DIALYSATE. 84
Renal insufficiency (RI) evolving to a definitive cure in sarcoidosic granulomatous nephritis (SGN) 84
Contribution of echotomography (ET) to transcutaneous renal needle-biopsy (RNB) and to the detection of possible complications 83
RISULTATI DELL’ECOCARDIOGRAFIA ESOFAGEA E TRANSTORACICA IN PAZIENTI IN EMODIALISI SENZA CARDIOPATIE CLINICAMENTE RILEVANTI 83
EFFETTI A MEDIO TERMINE DEL CALCITRIOLO NEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA E IPERPARATIROIDISMO LIEVE-MODERATO 83
THE COST/BENEFIT RATIO OF RENAL REPLACEMENT THERAPY 82
Determination of urinary albumin excretion in subclinical forms of glomerulonephritis by electroimmunodiffusion. 81
HEMOFILTRATION-INDUCED SERUM MODIFICATIONS IN THE PATTERN OF LARGER MOLECULES 80
QUANTIFICAZIONE DELL’EFFICIENZA DIALITICA PER L’UREA E PER LA BETA2 MICROGLOBULINA NELLE DIFFERENTI TECNICHE AD ALTO FLUSSO. 80
THE ROLE OF PLATELET-ACTIVATING FACTOR IN THE BIOCOMPATIBILITY OF HEMODIALYSIS MEMBRANES 79
PREDILUTION HEMOFILTRATION. CLINICAL EXPERIENCE AND REMOVAL OF SMALL MOLECULAR WEIGHT SOLUTES 79
IN VITRO AND IN VIVO BIOCOMPATIBILITY OF SUBSTITUTED CELLULOSE AND SYNTHETIC MEMBRANES 73
THE ROLE OF ADSORPTION IN 2-MICROGLOBULIN REMOVAL 71
SARCOID GRANULOMATOUS NEPHRITIS WITH ISOLATED AND REVERSIBLE RENAL FAILURE. A CASE REPORT. 69
Totale 8.398
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.980
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 0 0 0 3
2021/2022359 2 1 9 6 10 7 51 62 19 47 39 106
2022/20231.243 143 110 78 82 109 151 5 75 441 3 28 18
2023/2024326 29 56 12 9 37 67 0 29 9 15 25 38
2024/20251.607 33 89 95 43 194 286 7 65 217 153 125 300
2025/20262.864 272 246 309 164 463 171 349 61 396 234 138 61
Totale 8.398